Please login to the form below

Not currently logged in
Email:
Password:

pain management

This page shows the latest pain management news and features for those working in and with pharma, biotech and healthcare.

FDA committee rejects Intellipharmaceutics’ opioid drug Aximris

FDA committee rejects Intellipharmaceutics’ opioid drug Aximris

Aximris was developed as an abuse and alcohol-deterrent controlled-release oral formulation of oxycodone hydrochloride for pain relief. ... Intellipharmaceutics had been seeking approval for the management of pain severe enough to require daily,

Latest news

  • Galen completes acquisition of healthcare company POA Pharma Galen completes acquisition of healthcare company POA Pharma

    Galen is headquartered in Craigavon, Northern Ireland, and has products in therapy areas including gastroenterology, urology, female health, pain management and mental health. ... Simon Lawrence has been appointed as commercial director, Nordics as part

  • Big Pharma, Little Pharma Big Pharma, Little Pharma

    to dominate a particular ecological niche. Think penguins or wildebeest. We see other firms attempting similar evolution, such as Grunenthal with pain management and Ferring with women’s health.

  • AcelRX’s potent opioid tablets set to win FDA backing for pain relief AcelRX’s potent opioid tablets set to win FDA backing for pain relief

    We look forward to continued collaboration with the FDA on the application as we believe Dsuvia represents an important non-invasive acute pain management option with potential to significantly improve the ... BMIs. Meanwhile, Trevena’s intravenous

  • FDA awards another non-opioid pain drug breakthrough status FDA awards another non-opioid pain drug breakthrough status

    The US regulator yesterday awarded Concentric Analgesics and its pipeline drug CA-008 in post-surgical pain with an FDA Breakthrough Therapy designation (BTD). ... The announcement follows a BTD in June for Heron Therapeutics and its HTX-011, also for

  • The year of the blockbuster The year of the blockbuster

    Elagolix was filed for approval in the US in September 2017 for the management of endometriosis with associated pain. ... Endometriosis has no cure and requires symptomatic treatment. and a life-long management plan.

More from news
Approximately 2 fully matching, plus 71 partially matching documents found.

Latest Intelligence

  • Stepping out Stepping out

    For example, a recent study of pain management in Europe showed that some patients weren’t taking their medicines appropriately because they had concerns about becoming addicted.

  • How digital content helps HCPs curb opioid abuse through better prescribing decisions How digital content helps HCPs curb opioid abuse through better prescribing decisions

    On the other hand are the prescribers who are driven to help their patients but who are finding that their pain management protocols are now complicated by the treatment of an ... The pain management topic found under most specialties at Univadis

  • Deal Watch March 2016 Deal Watch March 2016

    Both companies have dermatology portfolios and with the acquisition of Putney, Dechra has also added anti-infective and pain management products to its own portfolio of endocrinology and ophthalmology products.

  • Pharma deals in June 2015 Pharma deals in June 2015

    Licence, collaboration. 364. Spinifex Pharmaceuticals/ Novartis. Lead candidate EMA401 - oral treatment for chronic pain, particularly neuropathic pain (p2). ... Neosaxitoxin, novel anaesthetic for local anaesthesia and post-op pain management.

  • Pharma deals during August 2014 Pharma deals during August 2014

    CL-108 has recently successfully completed a phase 3 study in the treatment of moderate to severe acute pain and the reduction of OINV. ... This acquisition will compliment and strengthen Medtronic's neuromodulation leadership position in the areas of

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics